Knowledge Management System of Kunming Institute of Botany,CAS
基于酚酸类结构研究抗流感病毒、 新冠病毒前体药物 | |
侯博 | |
导师 | 周俊 |
关键词 | 乙酰化酚酸环, 流感病毒, 新冠病毒, 抑制剂 Acetylflicinic acid cycle, Flu virus, SARS-CoV-2, Inhibitors |
摘要 | 季节性流感与新冠病毒的爆发在成人与小孩之间广泛传播, 不仅感染率高 而且造成全球成千上万人死亡。 近年来出现的耐药株具有高变异性、 高感染率、高致病性特点, 加之现有药物耐药、 供需不均、 高价使得开发新的抗病毒药物极为迫切。 化合物 zd-5 能简单、 有效的大规模合成, 具有双靶点抑制( HA、 NA)效果, 体外抗 A/B 型流感病毒活性在 0.52 uM-7.13 uM 之间, 该化合物的有效性与安全性在动物实验中得到观察与证实。另一方面的工作是针对当前抗新冠病毒药物的稀缺性与有限性, 应用基于靶点筛选方法, 结合 LC/MS 导向分离手段从大羽鳞毛蕨( Dryopteris wallichiana) 中获得了在 Vero E6 细胞上有效果的化合物3, 靶点研究揭示该类化合物主要作用于新冠病毒 3CLpro 蛋白。 本研究提供了抗流感病毒活性化合物 zd-5 与抗新冠病毒活性分子 3, 它们有助于新的抗病毒药物开发与利用。; Outbreaks of virus including the seasonal flu and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have spread throughout grown-ups and kids, within high infected rate and killing up to thousands of people in global annually. Highly variable, contagious, and pathogenic occasional drug-resistant strains emerged in recent years. In addition, existing drugs are resistant, overpriced and short supplies have highlighted the need to develop novel anti-virus therapeutics. Compound zd-5 can be synthesized simply and efficiently in large scale, having activities of NA and HA, and the anti-influenza activities of the Flu A/B is about 0.52 uM-7.13 uM, the evidence of safety and efficacy of zd-5 were observed and confirmed by experimental animals suffered from the flu in the work as well. On the other hand, there are only a few effective antiviral drugs available for the prophylactic or therapeutic treatment of the highly contagious SARS-CoV-2 in humans. Target-based virtual screening of Dryopteris with LC/MS guidance was applied to identify the novel and high-content compounds with inhibitory effects on SARS-CoV-2 in Vero E6 cells from the plant Dryopteris wallichiana. The inhibition assay of targets showed that compound 3 mainly inhibited SARS-CoV-2 3CLpro, with effective test values. This study has led to the development of zd-5 and compound 3-4 for exploring and designing inhibitors for the Flu virus and SARS-CoV-2. |
语种 | 中文 |
2022-04 | |
学位授予单位 | 中国科学院大学 |
文献类型 | 学位论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/75141 |
专题 | 昆明植物所硕博研究生毕业学位论文 |
推荐引用方式 GB/T 7714 | 侯博. 基于酚酸类结构研究抗流感病毒、 新冠病毒前体药物[D]. 中国科学院大学,2022. |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
侯博-1-博士后研究工作报告-侯博-26(7912KB) | 学位论文 | 限制开放 | CC BY-NC-SA | 请求全文 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[侯博]的文章 |
百度学术 |
百度学术中相似的文章 |
[侯博]的文章 |
必应学术 |
必应学术中相似的文章 |
[侯博]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论